Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy

BACKGROUND: Children treated for a malignancy are at risk to develop serious illness from a COVID-19 infection. Pegylated E. coli asparaginase (PEG-asparaginase) is used in the treatment of acute lymphoblastic leukemia. Allergy to this drug is common and both asparaginase and polyethylene glycol (PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Broos, Nancy, Brigitha, Leiah J., Schuurhof, Annemieke, Röckmann-Helmbach, Heike, Tissing, Wim J.E., Pieters, Rob, van der Sluis, Inge M., Stadermann, Marike B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788842/
https://www.ncbi.nlm.nih.gov/pubmed/38013843
http://dx.doi.org/10.1016/j.ejcped.2022.100002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788842/
https://www.ncbi.nlm.nih.gov/pubmed/38013843
http://dx.doi.org/10.1016/j.ejcped.2022.100002

Ejemplares similares